JAMES LIU

Profile

First Name

: JAMES

Middle Name

:

Last Name

: LIU

Related Companies
Titles
Company Name
Related People
DIRECTOR
MONEYPARK, INC.
ANDY CARRA, CHRISTOPHER CONWAY, JOBE DANGANAN, LEO GRUNSTEIN, STEFAN HEITMANN, ARKADI KUHLMANN, DEEPAK KUMAR, MARK LAWIN, BRAD LENSING, EDWARD MARTIN, DANIEL MORRIS, ROBERT PURNELL, TONY SACHS, NICK STAMOS, MARKUS STOCKER, ROGER UMBRICHT, GINGER WILCOX, ORI ZOHAR
DIRECTOR
SINDEO, INC.
ANDY CARRA, CHRISTOPHER CONWAY, JOBE DANGANAN, LEO GRUNSTEIN, STEFAN HEITMANN, ARKADI KUHLMANN, DEEPAK KUMAR, MARK LAWIN, BRAD LENSING, EDWARD MARTIN, DANIEL MORRIS, ROBERT PURNELL, TONY SACHS, NICK STAMOS, MARKUS STOCKER, ROGER UMBRICHT, GINGER WILCOX, ORI ZOHAR
DIRECTOR
SHIFTGIG, INC.
SEAN CASEY, JOHN CUMMINS, JILL ERICKSON, MICHAEL GAMSON, EDDIE LOU, JACK MURPHY, JEFF PIETA, SAM YAGAN, MICHAEL YOCH
DIRECTOR
ONERENT, INC.
ARMAN DEZFULI-ARJOMANDI, CHARLES HATTEMER, YIFENG HUANG, LAI SZE LAM, JAMES JIAN LIU, RICO MOK, ROBERT MOLES, JIM MORRISSEY, XIU QUAN QUAN, YANG XIU QUAN, GREG TOSCHI, MYRON VON RAESFELD, MICHAEL ZEE
EXECUTIVE OFFICER
ZADIG CAPITAL PARTNERS LP
SAME ZADIG CAPITAL GP LLC, SAME ZADIG CAPITAL MANAGEMENT LLC
EXECUTIVE OFFICER, DIRECTOR
ONCOCYTE CORP
RONALD ANDREWS, RONALD A ANDREWS, WILLIAM ANNETT, ANDREW ARNO, ANDY ARNO, DON BAILEY, JENNIFER LEVIN CARTER, KAREN B. CHAPMAN, MELINDA GRIFFITH, ANDREA JAMES, ALFRED KINGSLEY, ALFRED D KINGSLEY, ALFRED D. KINGSLEY, ANDREW LAST, ANDREW J LAST, MITCH LEVINE, MITCHELL LEVINE, KRISTINE C. MECHEM, ADITYA MOHANTY, ALBERT PARKER, ROBERT W. PEABODY, CAVAN REDMOND, JOSHUA RIGGS, DOUGLAS T ROSS, LOUIS SILVERMAN, RUSSELL SKIBSTED, PADMAVATHI SUNDAR, JOSEPH WAGNER, MICHAEL WEST
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-04-24
D/A
Link
HEDGE FUND 
 
 
Equity 
2021-05-04 
2025-02-24
D
Link
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2025-02-10 
2024-10-08
D
Link
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2024-10-02 
2024-04-29
D/A
Link
HEDGE FUND 
 
 
Equity 
2021-05-04 
2024-04-25
D
Link
BIOTECHNOLOGY 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
DECLINE TO DISCLOSE 
Equity 
2024-04-11 
2023-04-25
D/A
Link
HEDGE FUND 
 
 
Equity 
2021-05-04 
2022-04-28
D/A
Link
HEDGE FUND 
 
 
Equity 
2021-05-04 
2021-05-10
D
Link
HEDGE FUND 
 
 
Equity 
2021-05-04 
2019-03-20
D
Link
RESIDENTIAL 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-04 
2018-08-09
D/A
Link
RESIDENTIAL 
 
$1,000,001 - $5,000,000 
Debt 
2016-09-14 
2018-01-12
D/A
Link
RESIDENTIAL 
 
$1,000,001 - $5,000,000 
Debt 
2016-09-14 
2017-01-23
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-01-09 
2016-09-30
D
Link
RESIDENTIAL 
 
$1,000,001 - $5,000,000 
Debt 
2016-09-14 
2016-09-28
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-16 
2016-09-23
D
Link
OTHER BANKING AND FINANCIAL SERVICES 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-20 
2016-03-23
D
Link
RESIDENTIAL 
 
$1 - $1,000,000 
Equity 
2016-03-18 
2015-11-25
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-11-10 
2015-11-12
D
Link
OTHER BANKING AND FINANCIAL SERVICES 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-29 
2015-09-04
D
Link
OTHER BANKING AND FINANCIAL SERVICES 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-28 
2015-05-12
D
Link
OTHER BANKING AND FINANCIAL SERVICES 
 
DECLINE TO DISCLOSE 
Equity 
2015-04-29 
2015-01-12
D
Link
OTHER BANKING AND FINANCIAL SERVICES 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-31